Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in ADPKD
NCT02494141Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2015
- Primary completion
- Feb 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of curcumin in autosomal dominant polycystic kidney disease (ADPKD), sponsored by University of Colorado Denver. Started Nov 2015; status: completed.
02
Drugs
curcumin
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02494141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494141.